These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oral zinc therapy normalizes serum uric acid level in Wilson's disease patients. Umeki S; Ohga R; Konishi Y; Yasuda T; Morimoto K; Terao A Am J Med Sci; 1986 Nov; 292(5):289-92. PubMed ID: 3777013 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a urate reabsorptive defect in patients with Wilson's disease. Wilson DM; Goldstein P Adv Exp Med Biol; 1974; 41():729-37. PubMed ID: 4832602 [No Abstract] [Full Text] [Related]
4. Analysis of risk factors for fatty liver disease in children with Wilson's disease. Jia SP; Wang MX; Tao Z; Gao YN; Yu GR; Yang WM Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1046-1053. PubMed ID: 38874972 [TBL] [Abstract][Full Text] [Related]
5. Hypercalciuria in hepatolenticular degeneration (Wilson's disease). Randall RV; Goldstein NP; Gross JB; Rosevear JW Am J Med Sci; 1966 Dec; 252(6):715-20. PubMed ID: 5954673 [No Abstract] [Full Text] [Related]
6. [The Correlation between Blood Uric Acid and Goldstein Grading in Hepatolenticular Degeneration Patients with Different Chinese Medical Syndrome Types]. Hu JY; Han YZ; Ye QR; Hong MF; Cai YL; Ren MS; Pan FM; Wang X; Yang RM Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Nov; 35(11):1335-9. PubMed ID: 26775481 [TBL] [Abstract][Full Text] [Related]
7. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). SCHEINBERG IH; GITLIN D Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898 [No Abstract] [Full Text] [Related]
8. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease). SCHEINBERG IH Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521 [No Abstract] [Full Text] [Related]
9. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058 [No Abstract] [Full Text] [Related]
10. The effects of penicillamine therapy on uric acid metabolism in Wilson's disease. Sorensen LB; Kappas A Trans Assoc Am Physicians; 1966; 79():157-64. PubMed ID: 5954284 [No Abstract] [Full Text] [Related]
11. Renal urate excretion in patients with Wilson's disease. Wilson DM; Goldstein NP Kidney Int; 1973 Nov; 4(5):331-6. PubMed ID: 4762580 [No Abstract] [Full Text] [Related]
12. Renal impairment in different phenotypes of Wilson disease. Wang H; Zhou Z; Hu J; Han Y; Wang X; Cheng N; Wu Y; Yang R Neurol Sci; 2015 Nov; 36(11):2111-5. PubMed ID: 26219584 [TBL] [Abstract][Full Text] [Related]
17. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease]. Kanai M; Nomoto S; Tsukagoshi H; Shindo M Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793 [No Abstract] [Full Text] [Related]
18. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease. SCHEINBERG IH; MORELL AG J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081 [No Abstract] [Full Text] [Related]
19. A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease. AISEN P; SCHORR JB; MORELL AG; GOLD RZ; SCHEINBERG IH Am J Med; 1960 Apr; 28():550-4. PubMed ID: 13792199 [No Abstract] [Full Text] [Related]
20. [Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage]. Degli Esposti A; Antener I; Ambrosioni G; Bonfiglioli G Minerva Pediatr; 1976 Nov; 28(34):2063-86. PubMed ID: 1012227 [No Abstract] [Full Text] [Related] [Next] [New Search]